Petros Grivas, MD, PhD - On Target: Integrating Trop-2-Directed Therapeutics for Urothelial Carcinoma With Precision

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/NCPD/AAPA/IPCE information, and to apply for
credit, please visit us at PeerView.com/ZDU865.
CME/NCPD/AAPA/IPCE credit will be available until June 25, 2025.


On Target: Integrating Trop-2-Directed Therapeutics for
Urothelial Carcinoma With Precision


In support of improving patient care, this activity has been
planned and implemented by PVI, PeerView Institute for Medical
Education, and Bladder Cancer Advocacy Network. PVI, PeerView
Institute for Medical Education, is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME),
the Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis activity has been supported by
an independent educational grant from Gilead Sciences, Inc.


Disclosure information is available at the beginning of the video
presentation.